Skip to content
BlueDopamine

Company · About

A UK startup using AI to help scientists decide what to make

North East England
Since 2019

We focus on leveraging artificial intelligence to design and modify proteins and small molecules.

CANDIDATESTO TEST · AND WHYCHOOSE, AND SHOW THE REASONING

01 · Who we are & what we do

BlueDopamine is a young company in North East England building AI tools for protein, enzyme and peptide design. We combine design, biological context and a clear record of every decision, so small research teams can work with the confidence of a much larger lab.

BlueDopamine is a trailblazer in the biotechnology industry, focused on leveraging artificial intelligence to revolutionize the design of proteins, vaccines, and drugs. Our core mission is to harness the power of advanced AI algorithms and molecular modeling to push the boundaries of protein engineering. We provide innovative solutions that enable precise, efficient, and customizable biomolecule design for a range of applications in medicine, environmental sustainability, and beyond. By blending cutting-edge technology with deep biological insights, BlueDopamine is not just responding to the challenges of today but is actively shaping the future of healthcare and biotechnology.

02 · Mission

Help researchers choose the right candidates to test, and show their reasoning.

03Our story

2019–2026
  1. RESEARCH BEGINS
    2019
    Start of the JourneyWe embarked on our mission to revolutionize protein and molecule design with AI, initiating research on developing our platform.
  2. MOLECULE DESIGN
    2020
    Start Development of Molecule Design ModelBegan crafting an AI model focused on accelerating the discovery and design of novel molecules.
  3. PROTEIN DESIGN
    2021
    Protein Design Model DevelopmentWe initiated the development of an AI-driven protein design model to engineer novel proteins with bespoke functionalities.
  4. PROTEIN · DRUGPROTEIN–DRUG INTERACTION
    2022
    Protein-Drug Interaction Model DevelopmentWe started creating a model to predict protein-drug interactions, aiming to enhance the development of safer, more effective drugs.
  5. ACADEMICSPLATFORMFIRST ACADEMIC ACCESS
    2023
    Starting Evaluating Our ModelsWe began evaluating our platform by granting access to some academics, who are assessing its utility in their projects.
  6. UNITED KINGDOMBASED IN THE UK
    2026
    The company is based in the UK

04Recognition

4 awards

BlueDopamine has quickly gained attention for its innovative approach to AI in medicine. The startup’s work has been recognised through the awards showcased in this section.

These accolades underscore BlueDopamine’s position at the forefront of AI in medicine, with judges and industry experts citing its innovative approach to key parts of molecular modelling and protein engineering.

  • 2025WINNER
    Winner · 2025Rayan AI CompetitionHosted by Sharif University
  • 2024RUNNER-UP
    Runner-up · 2024Elecomp Stars Pitch CompetitionThe biggest startup competition of Iran, held in the Elecomp exhibition, the largest exhibition for electronic and computer products
  • 2024RUNNER-UP
    Runner-up · 2024Inotex Pitch CompetitionOne of the most important international innovation and startup platforms of Iran
  • 2023WINNER
    Winner · 2023Iran Artificial Intelligence Awards (IAAA)Held in Tehran

05Where we are

NEWCASTLENORTH EAST ENGLANDWHERE WE ARE
Newcastle · North East England

Based at Northumbria University's start-up programme in Newcastle.

Registered in England and Wales.

Company number to be added

06The team

10 people
Meet the team

Work with us.

We are open for cooperation. Let's bring your creative ideas to life together!